<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd" MadCap:lastBlockDepth="6" MadCap:lastHeight="874" MadCap:lastWidth="876" xmlns:MadCap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
    <head>
        <link href="../Resources/TableStyles/dnb_tablestyle_1.css" rel="stylesheet" MadCap:stylesheetType="table" />
    </head>
    <body>
        <h1>
   Taro Pharmaceutical Industries Ltd.
  </h1>
        <div style="display: none;">
            <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <thead>
                    <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
                    </tr>
                </thead>
                <tbody>
                    <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
        600072078
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       89531
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
                    </tr>
                </tbody>
            </table>
        </div>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" />
        <p>
   Taro Pharmaceutical Industries makes affordable drugs for cardiac, dermatological, neurological, and pediatric illnesses. It manufactures and markets generic prescription and over-the-counter (OTC) drugs, primarily in North America and Israel. It also produces private label and branded drugs. Its facilities are capable of producing topical, oral, and injectable formulations. The company also produces active pharmaceutical ingredients (APIs) for use by its own facilities and sold to other drugmakers. Its customers include wholesalers, drugstore and grocery chains, and discount retailers. India's
   <company id="159766">
    Sun Pharmaceutical
   </company>
   owns a controlling stake in Taro.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Geographic Reach.flsnp" />
        <p>
   The US accounts for more than three-fourths of Taro's annual revenues; its two other key markets are Canada and Israel.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Operations.flsnp" />
        <p>
   Within its primary markets, Taro makes about 200 generic and OTC products, including oral cardiovascular and neurological prescription drugs, as well as prescription and OTC dermatological creams, ointments, and gels. It also makes a variety of pain and fever medications, nasal sprays, and eye care products for the domestic Israeli market. The company's top-selling products are desoximetasone (sold as Topicort in some markets), a topical corticosteroid for inflammation, and generic warfarin (Coumadin), a blood thinner sold in North America, the UK, Israel, and other global markets.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Strategy.flsnp" />
        <p>
   Taro Pharmaceutical routinely reinvests about 10% of its sales into research and development efforts for new products. It has also invested in manufacturing facility and information technology upgrades in recent years. The company's primary research and manufacturing locations are located in Israel and Canada; it ceased operations at its manufacturing and research center in Ireland in 2010.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
    </body>
</html>